Literature DB >> 1192142

Editorial: Immunotherapy for multiple sclerosis.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1192142      PMCID： PMC1675600          DOI： 10.1136/bmj.4.5995.486-a

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  11 in total

1.  A tissue-culture approach to demyelinative disorders.

Authors:  M B BORNSTEIN
Journal:  Natl Cancer Inst Monogr       Date:  1963-03

2.  Intensive immunosuppression in the treatment of multiple sclerosis.

Authors:  J Ring; J Seifert; G Lob; K Coulin; H Angstwurm; E Frick; B Brass; J Mertin; H Backmund; W Brendel
Journal:  Lancet       Date:  1974-11-09       Impact factor: 79.321

3.  Virus antibody levels in multiple sclerosis.

Authors:  C A Ross; J A Lenman; I D Melville
Journal:  Br Med J       Date:  1969-08-30

4.  [Destruction of nerve cells cultured "in vitro" by lymphocytes from patients with multiple sclerosis. Auto-immune pathogenesis of multiple sclerosis].

Authors:  B Halpern; P Bakouche; C Martial-Lasfargues
Journal:  Presse Med       Date:  1969-12-25       Impact factor: 1.228

5.  Effect of 'maximum immune suppression' with thoracic duct drainage, ALG, azathioprine and cortisone in some neurological disorders.

Authors:  W Brendel; J Seifert; G Lob
Journal:  Proc R Soc Med       Date:  1972-06

6.  In vitro delayed (cellular) hypersensitivity in multiple sclerosis to central nervous system antigens.

Authors:  H Bartfeld; T Atoynatan
Journal:  Int Arch Allergy Appl Immunol       Date:  1970

7.  Viral antibody in the cerebrospinal fluid and serum of multiple sclerosis patients.

Authors:  J K Clarke; D S Dane; G W Dick
Journal:  Brain       Date:  1965-12       Impact factor: 13.501

8.  Antibodies to measles antigen, control antigen, and monkey kidney antigen. Studies in patients with multiple sclerosis and other neurological diseases and normal healthy individuals.

Authors:  E A Caspary; M E Chambers; E J Field
Journal:  Neurology       Date:  1969-11       Impact factor: 9.910

9.  Measles antibodies in patients with multiple sclerosis.

Authors:  J M Adams
Journal:  Neurology       Date:  1967-07       Impact factor: 9.910

10.  Paramyxovirus-like particles associated with acute demyelination in chronic relapsing multiple sclerosis.

Authors:  J Prineas
Journal:  Science       Date:  1972-11-17       Impact factor: 47.728
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.